Mandate

Vinge advises Schwarz Group on the market entry of its environmental division PreZero in Sweden in connection with PreZero's acquisition of SUEZ’s waste management and recycling operations in Sweden.

SUEZ has more 50 recycling sites and around 1,000 employees in Sweden.

The transaction is subject to antitrust clearance and closing of the transaction is expected at the end of 2020.

Vinge's team consisted of Matthias Pannier, Ulrich Ziche, Linda Sengul and Jesper Lindvall together with Nina Gransäter (M&A), Mathilda Persson, Jolene Reimerson, Mika Jordan, Ellinor Wargenbrant, Christoffer Nordin, Lisa Hörnqvist, Marion Kronberg and Hayaat Ibrahim (IT & Commercial Agreements), Johan Cederblad and Olof Löfvenberg (Environmental & permits), Sara Strandberg and Veronika Garemark (Employment), Jack Bengtsson and Martin Svanberg (Financing), Sofia Bergenstråhle (IP), Kristoffer Larson (Real Estate), Maria Schultzberg (Tax), Nathalie Hughes and Carl Bruneheim (VDR assistants) as well as Jasmina Skandrani (Project assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025